B2B Services Portfolio
Unbiased clinical proteomics, cellular models, bioinformatics engines, and regulatory certifications to de-risk cancer therapeutics development.
Choose the Right Proteomics Service
Use this hub to compare Yatiri Bio services by study stage, sample type, and clinical translation goal before opening a technical service page.
Discovery & Global Proteomics
Unbiased, deep mass spectrometry profiling measuring over 8,000 distinct proteins in a single sample. Map cellular baseline proteomes across various matrices to isolate responsive subset signatures.
PTM & Phosphoproteomics
Map active post-translational modifications (PTMs). Isolate phosphorylated peptides to build complete maps of active intracellular kinase signaling and discover novel targeted escape pathways.
ProteoModels Efficacy Testing
Evaluate your therapeutic compounds against our repository of patient-derived ex-vivo tumor models. Correlate drug response directly with baseline proteomic activation datasets.
AI & Bioinformatics Analysis
Run custom machine-learning feature selections and pathway network enrichment mappings. Interact with datasets via our proprietary browser systems (ProteoBrowser™, ProteoPathway™).
CLIA Biomarkers & Companion Dx
Translate experimental protein signatures into certified companion diagnostic assay tests inside our NGeneBioAI CLIA/CAP laboratory facilities at Nancy Ridge Dr.
Translational Consulting
Design patient selection protocols and enrich trial designs with systems-level biomarkers to target specific tumor vulnerabilities and lower failure rates.
How Buyers Typically Use This Portfolio
Discovery
Start with global proteomics or phosphoproteomics when target biology, resistance pathways, or responder subsets are not yet clear.
Validation
Use ProteoModels and AI bioinformatics to connect baseline protein states with ex-vivo drug sensitivity and pathway response.
Clinical Translation
Move qualified signatures into CLIA/CAP biomarker assays and translational consulting for patient-selection trial design.